Uncategorised - European Medical Journal

Liraglutide Effective for Children with Obesity Aged Under 12 Years: EASD 2024

The SCALE Kids trial has found that weight-loss drug liraglutide is safe and effective for children aged 6 to under 12 years living with obesity.

Students Struggle with Dermatology Education Lacking in Diversity

Gaps in dermatology education have been spotlighted in preclinical medical students.

Breast Cancer Risk After Bariatric Surgery

In a new, nonrandomised controlled trial, researchers have found that breast cancer risk was lower in individuals who had undergone bariatric surgery.

The ITP Treatment Landscape

The limitations of currently available therapies for immune thrombocytopenia (ITP) mean that long-term responses are difficult to maintain…

Answering the Patient’s Call: A Move Towards Personalized Primary Biliary Cholangitis Care

The key to personalized care for patients with primary biliary cholangitis (PBC) starts with good and effective dialogue between the…

Season 7 highlights: GOLD Medal Moments

The new season of the podcast is only a week away, so before we get started – why not have a listen to some of the best bits from Series 7?

Study Finds New Factors Associated with Lower Liver Cancer Risk

Declines in serum hepatitis B virus RNA during the first and second year of treatment with nucleoside analogues could be indicators of reduced risk for hepatocellular carcinoma.

Study Reveals Gender Disparity in Liver Transplants

A recent study has highlighted a concerning gender disparity in access to liver transplants showing that women on the liver transplant waiting list are less likely to undergo a transplant

FDA lifts partial clinical hold on Rezolute hyperinsulinism treatment

The lift is based on new research showing that the previous adverse effects in laboratory rats may not have been caused by the drug itself.

New AI-focused RNA collaboration for Eli Lilly

Eli Lilly has entered into a research collaboration with Genetic Leap, a private company focused on AI, to advance the development of RNA-based genetic medicines.